Novavax, Inc.

NASDAQ:NVAX  
209.53
+4.59 (+2.24%)
4:53:49 PM EDT: $207.99 -1.54 (-0.74%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)15.88B
Current PEN/A
Forward PE N/A
2yr Forward PE 6.94
See more stats
Estimates Current Quarter
Revenue$387.87 Million
Adjusted EPS-$3.63
See more estimates
10-Day MA$188.85
50-Day MA$181.04
200-Day MA$153.23
See more pivots

Novavax, Inc. Stock, NASDAQ:NVAX

21 Firstfield Road, Gaithersburg, Maryland 20878
United States of America
Phone: +1.240.268.2000
Number of Employees: 791

Description

Novavax, Inc. focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It provides vaccines for COVID-19, seasonal flu, respiratory syncytial virus, Ebola, and Middle East respiratory syndrome. The company was founded in 1987 and is headquartered in Gaithersburg, MD.